President Donald Trump is forging ahead with his plan to overhaul and shrink the federal government. The effort led by Elon Musk’s DOGE is facing a variety of legal challenges, which have halted ...

ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00.

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

An Indian astronaut - or a Gaganyatri - will soon travel to the International Space Station (ISS), and a groundbreaking India ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...

According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected to reach around USD 186.09 billion by 2034, growing at a CAGR of 4.4% from ...

About Portage Biotech, Inc. Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more ...

Heid, a China hawk who helped set technology policy for the congressional committee, is being tapped to be assistant ...